15. Histopathological features and outcomes of poorly differentiated thyroid carcinoma
Jay Goswamy(Manchester University NHS Foundation Trust), Ricard Simó(Guy's Hospital), Edward Odell(Guy's Hospital), Mary Lei(Guy's and St Thomas' NHS Foundation Trust), Mufaddal Moonim(Charing Cross Hospital), Rose Ngu(St Thomas' Hospital), Paul Carroll(Guy's and St Thomas' NHS Foundation Trust), Johnathan Hubbard(St Thomas' Hospital), Ash Chandra(St Thomas' Hospital), Jake Powrie(Guy's and St Thomas' NHS Foundation Trust), Hosahalli Mohan(St Thomas' Hospital), Jean‐Pierre Jeannon(Guy's and St Thomas' NHS Foundation Trust)
Cited by 0
Related Papers
Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer
|European Journal of Cancer|2015|386
Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes
|Diabetes|2014|244
Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes
|Science Translational Medicine|2017|215
Peripheral and Islet Interleukin-17 Pathway Activation Characterizes Human Autoimmune Diabetes and Promotes Cytokine-Mediated β-Cell Death
|Diabetes|2011|213
Self‐monitoring in Type 2 diabetes mellitus: a meta‐analysis
|Diabetic Medicine|2000|177